Treatment of osteoarthritis with acetaminophen: efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs.

被引:20
|
作者
Shamoon M. [1 ]
Hochberg M.C. [1 ]
机构
[1] Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, MSTF 8-34, 10 S. Pine Street, Baltimore, 21201, MD
关键词
Osteoarthritis; Ibuprofen; Acetaminophen; Naproxen; Acetami;
D O I
10.1007/s11926-000-0020-z
中图分类号
学科分类号
摘要
Osteoarthritis represents a major public health problem with limited effective treatment. Nonsteroidal anti- inflammatory drugs (NSAIDs) are widely used to alleviate symptoms such as pain and stiffness. However, these drugs are associated with an increased risk for the development of adverse sequelae, including serious upper gastrointestinal side effects such as symptomatic ulcers, perforation, obstruction, and gastrointestinal bleeding. The simple analgesic acetaminophen has been found to be effective in alleviating pain in patients with osteoarthritis in a placebo-controlled trial, and several trials have evaluated its efficacy and safety compared with NSAIDs. This article reviews data regarding the efficacy and safety of acetaminophen in the treatment of osteoarthritis from randomized, controlled, clinical trials, focusing on studies that compared acetaminophen with NSAIDs. In addition, literature on physician and patient preferences in this area are examined. In summary, judicious use of analgesic agents as pharmacologic therapy in patients with osteoarthritis will achieve satisfactory pain relief in most cases. Acetaminophen merits a trial as initial therapy in patients with mild to moderate pain, based on cost-effectiveness and safety profile.
引用
收藏
页码:454 / 458
页数:4
相关论文
共 50 条
  • [41] MAXIMIZING SAFETY WHEN PRESCRIBING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    CLINCH, D
    WALLER, DG
    IRISH MEDICAL JOURNAL, 1989, 82 (04) : 172 - 177
  • [42] Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
    Maillard, M
    Burnier, M
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (01) : 83 - 94
  • [43] Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk
    Naumov, A., V
    Tkacheva, O. N.
    Khovasova, N. O.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (01) : 108 - 113
  • [44] Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients
    Pham, Hoang X.
    Mullins, Michael E.
    CLINICAL TOXICOLOGY, 2018, 56 (11) : 1121 - 1127
  • [45] UNDERSTANDING ETHNIC DIFFERENCES IN THE UTILIZATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR OSTEOARTHRITIS
    Vina, Ernest
    Hannon, Michael
    Dagnino, Jazmin
    Kwoh, C. Kent
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 605 - 605
  • [46] Osteoarthritis in Older Adults: Nonsteroidal Anti-Inflammatory Drugs Versus Opioids
    Banks, Callan
    Hughes, Krystal
    Simpkins, Cassandra
    Elliott, David P.
    SENIOR CARE PHARMACIST, 2019, 34 (10): : 674 - 677
  • [47] Pharmacological management of osteoarthritis judicious use of nonsteroidal anti-inflammatory drugs
    Lee, Hanna
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (10): : 635 - 640
  • [48] Do nonsteroidal anti-inflammatory drugs accelerate disease progression in osteoarthritis?
    Steven B Abramson
    Nature Clinical Practice Rheumatology, 2006, 2 : 302 - 303
  • [49] Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs
    Stanos, Steven P.
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2013, 6 : 133 - 137
  • [50] Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study
    Essex, Margaret N.
    O'Connell, Michael A.
    Behar, Regina
    Bao, Weihang
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (03) : 262 - 270